Targeted Cancer Drugs Could Invoke Pediatric Rule, Advisory Cmte. Says
Executive Summary
FDA could mandate pediatric studies for targeted oncologic agents by invoking the pediatric rule, members of the Oncologic Drugs Advisory Committee's Pediatric Subcommittee said June 28.